SB-505124: Difference between revisions

Revision as of 11:04, 15 January 2021

SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 .

SB505124 SB 505124 2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine

> 11 Xenbase articles contain a reference to SB-505124 according to textpresso

Revision as of 11:03, 15 January 2021 (view source) imported>Xenbase (Created page with "==Description== SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 . ==Alternative names== SB505124 SB 505124 2-[4-(1...")	Revision as of 11:04, 15 January 2021 (view source) imported>Xenbase m (Xenbase moved page SB 505124 to SB-505124) Newer edit →
(No difference)